Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sentivate is the next 10x
>Undiscovered Microcap Gem
>Alpha Product is out for Download: Closed Beta in October
https://social.sentivate.com/downloads/
>KuCoin Listing September Rumor.
>Active Community on Twitter & Telegram
https://twitter.com/sentivate/
>Navy Seal Co-Founder owner of Templar Titan “Providing Timely Solutions to Complex Scenarios.”
>Rumors of partnership floating with NTT DATA, a recognized leader in global technology services, ranked No. 3 in the 2019 IDC FinTech Rankings Top 100
>Strong Roadmap coming up with Exchanges, Closed Beta, and Mainnet Launch:
https://sentivate.com/info/roadmap/
>Strong Marketing Team
>Interviews and FAQ:
https://sentivate.com/info/faq/
https://uniswap.info/pair/0xAb9Bef8242c2B97772aE239A5d71c60496A06334
How to buy $SNTVT
-Go to https://uniswap.org/
-Launch App
-Link Wallet (Metamask/TrustWallet/Other)
-Swap Tokens
-Use ETH for the “From”
-Add $SNTVT by Contract address:
0x7865af71cf0b288b4e7f654f4f7851eb46a2b7f8
Verify contract at https://sentivate.com/info/
https://uniswap.info/pair/0xAb9Bef8242c2B97772aE239A5d71c60496A06334
Do your own research this is not Financial Advice.
Just Discovered COTI
Browsing and digging for new gems off CoinMarketCap I ran into COTI
COTI is a fintech platform that aims to solve the challenges of traditional payment systems by building an ecosystem that enables cheap, fast and fair payments to everyone.
Ran into the Blockfyre Report on it which scored 55/63 and did some sentiment check on Twitter and a lot of people are bullish on COTI! Check it out and decide for yourselves
https://drive.google.com/file/d/1SR5qDuKejcBNygOf-EI-GZfK88j0jdXd/view
Sentivate The Universal Web
https://sentivate.com
Shaping up to the next 1000x Ethereum :)
Sentivate The Universal Web
https://sentivate.com
Shaping up to the next 1000x Ethereum :)
ETHEREUM DARK... NEXT ETHEREUM BIG RUNNER
NEXT ETHEREUM $ETHD
DO YOUR OWN RESEARCH
https://www.cryptopia.co.nz/Exchange?market=ETHD_BTC
ETHEREUM DARK GET IN ON THE NEXT ETHEREUM $ETHD
DO YOUR OWN RESEARCH
https://www.cryptopia.co.nz/Exchange?market=ETHD_BTC
$LUX = $ARK + $XRP + $DASH, Privacy coin with Smart Contracts + Segwit, Brand New Algo PHI1612 POW/POS + unique Parallel Masternodes Concept! Hardfork Imminent!
http://luxcore.io/ https://luxcoin.tech/
Whitepaper: https://drive.google.com/file/d/0BxMSe9WkXwS6aWdvX3FkbUptbTg/view
DYOR, this is just my find on this...
LUXcoin is a unique privacy coin. Lux uses the PHI1612 algo which is currently present as the most efficient GPU mining algorithm. GPU friendly, and ASIC resitant. Higher hash rates, without increasing power consumption. Providing miners with more profitability due to lower electrical costs.
New concept of Parallel Masternodes: Software as a Service built on top of the blockchain. Allows creation of 3rd party centralized or decentralized private dApps.
Extremely Active Dev team which you can check on in https://github.com/216k155
Technical Breakdown for Beginners.
$LUX = $ARK + $XRP + $DASH, Privacy coin with Smart Contracts + Segwit, Brand New Algo PHI1612 POW/POS + unique Parallel Masternodes Concept! Hardfork Imminent!
http://luxcore.io/ https://luxcoin.tech/
Whitepaper: https://drive.google.com/file/d/0BxMSe9WkXwS6aWdvX3FkbUptbTg/view
DYOR, this is just my find on this...
LUXcoin is a unique privacy coin. Lux uses the PHI1612 algo which is currently present as the most efficient GPU mining algorithm. GPU friendly, and ASIC resitant. Higher hash rates, without increasing power consumption. Providing miners with more profitability due to lower electrical costs.
New concept of Parallel Masternodes: Software as a Service built on top of the blockchain. Allows creation of 3rd party centralized or decentralized private dApps.
Extremely Active Dev team which you can check on in https://github.com/216k155
Technical Breakdown for Beginners.
$ABPI EBOLA!
$ABPI EBOLA!
$GSML PRIMED FOR A RUN SOON ON THE RELEASE OF CANNABIS NEWS AND TICKER CHANGE
$GSML PRIMED FOR A RUN SOON ON THE RELEASE OF CANNABIS NEWS AND TICKER CHANGE
$SREH
Expecting MJ NEWS SOON.
$IGC - Cannabis Stock on the Big Boy Market! Running Hard ~ Major Volume
$IGC - Cannabis Stock on the Big Boy Market! Running Hard ~ Major Volume
$IGC running hard major volume!
MY PICK IS SLNX @ .0086
$SLNX Morning News! 100% BUY
http://www.otcmarkets.com/stock/SLNX/news/Solanbridge-Group-Inc--Finalizing-Acquisition-of-Colorado-Medical-Marijuana-Product-Producer?id=80020&b=y
$MCII set for a breakout as well
$GSML is due for news soon. Cannabis Holdings Inc.
My pick will be $CWIR
$GSML is due for news soon. Cannabis Holdings Inc.
$GSML is due for news soon. Cannabis Holdings Inc.
$GSML is due for news soon. Cannabis Holdings Inc.
$GSML / Cannabis Holdings Inc. - Pick it up on a discount while you can!
Company Announces Resignation of Board of Directors and Introduces New Management Team
HENDERSON, NV / ACCESSWIRE / April 15, 2014 / G&S Minerals, Inc. (OTC: GSML) today announced that the Company has officially changed its name to Cannabis Holdings, Inc. in order to reflect its new business model and operations has relocated its headquarters to Colorado to take advantage of the state’s growing cannabis market.
Cannabis Holdings plans to enter the rapidly growing hemp market in the United States. The Company will introduce a new executive management team and Board of Directors to position itself for rapid growth in this new market and is in the process of updating its corporate website and information. The Company has also applied for a new stock ticker from the OTC Markets.
Cannabis Holdings also reports the resignation of Edward Hanjoul, Ron Jost and Donald Ross from its Board of Directors. Mr. Hanjoul has also resigned as Chief Executive Officer and William Smith has resigned as Corporate Secretary and Treasurer. The Company plans to announce its new management team and other developments in the near future.
$GSML / Cannabis Holdings Inc. - Pick it up on a discount while you can!
Company Announces Resignation of Board of Directors and Introduces New Management Team
HENDERSON, NV / ACCESSWIRE / April 15, 2014 / G&S Minerals, Inc. (OTC: GSML) today announced that the Company has officially changed its name to Cannabis Holdings, Inc. in order to reflect its new business model and operations has relocated its headquarters to Colorado to take advantage of the state’s growing cannabis market.
Cannabis Holdings plans to enter the rapidly growing hemp market in the United States. The Company will introduce a new executive management team and Board of Directors to position itself for rapid growth in this new market and is in the process of updating its corporate website and information. The Company has also applied for a new stock ticker from the OTC Markets.
Cannabis Holdings also reports the resignation of Edward Hanjoul, Ron Jost and Donald Ross from its Board of Directors. Mr. Hanjoul has also resigned as Chief Executive Officer and William Smith has resigned as Corporate Secretary and Treasurer. The Company plans to announce its new management team and other developments in the near future.
$SLNX - Real MMJ company making moves. Bought in at .0009 :)
$SLNX - Real MMJ company making moves. Bought in at .0009 :)
$SLNX - Real MMJ company making moves. Bought in at .0009 :)
Bought into $SLNX at .0009. So glad I did :) Still holding! @emortal7 on twitter
Thin above 35s
$SLNX May 1st News
Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen
May 01, 2014
OTC Disclosure & News Service
Houston, TX -
Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen
May 1 2014
Houston ? Solanbridge Group Inc. (OTC: SLNX) is pleased to announce the appointment of Dr. Mark T. Cullen to the Scientific Advisory Board of SLNX. "We are proud to announce that Dr. Mark Cullen has agreed to join our Board to develop medical products that utilize cannabidiol (?CBD?), one of the many active ingredients derived from marijuana,? stated Charles R. Shirley, Chairman of the Board and Managing Director of Solanbridge. ?Dr. Cullen?s amazing career as a medical doctor, a chemist, a researcher, and as an entrepreneur makes him uniquely qualified to develop products for Solanbridge that break new ground in the development of uses for CBD beyond the currently known uses for the treatment of brain damage, severe social anxiety, cancer, psychological disorders,? Shirley continued. ?We realized that with Dr. Cullen?s physical presence in the Lake Tahoe area that this is a part of the medical marijuana business that we can take immediately to the market in Nevada and California without having an indeterminate wait for licenses or other regulatory issues,? Shirley added. Nevada and California have already approved medical marijuana for patients.
Dr. Cullen?s resume fits nicely with the development of medical marijuana products. He is a Yale University-trained doctor and medical director, who had academic appointments at Yale University and University of Florida. Dr. Cullen has done collaborative work with the World Health Organization (WHO), the Center for Disease Control (CDC) and the National Institute of Health (NIH). He has been published in numerous periodicals and has contributed to an educational movie series by National Geographic. He is an entrepreneur who has developed start-up companies and has also worked as the CEO of multiple companies both public and private. He is an inventor who has created ultrasound desulfurization and heavy oil upgrade technology. His work has taken him throughout the world including Saudi Arabia, UAI, India, and South America.
Solanbridge is also encouraged by the changing public opinion landscape in certain U.S. jurisdictions and the potential for legislative changes toward less regulation of medical marijuana and potentially recreational marijuana use in Nevada, Alaska, Oregon, and Rhode Island. Medical marijuana is legal in 20 states. There is a movement toward medical marijuana legalization in Florida and Maryland, two jurisdictions where Solanbridge has a physical presence.
The Company continues to pursue a commercial grower?s license in Province of Nova Scotia. Plans have been developed to hire a full-time staff member to administer the application process, acquire a building, equip the building with a state-of-the-art security system, and build out all aspects of a commercial medical marijuana grower?s production facility. The MOU signed by the Company on March 29, 2014 still plans to close on time.
About Solanbridge Group Inc.
Solanbridge Group Inc. is based in Spring, Texas and is a diversified holding company looking to expand into the medical marijuana industry by developing a commercial grower?s license in the Province of Nova Scotia, Canada. Solanbridge's subsidiary, David's Steak and Seafood, in Melbourne Beach, Florida, is a classic, upscale steak house, which presents polished dining in an atmosphere of timeless elegance, offering guests the finest cuts of choice USDA meats, fresh seafood and much more.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Contact:
For further information, please contact:
Charles R. Shirley
Solanbridge Group Inc
charles@solanbridgegroup.com
832.225.1372
Copyright © 2014 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
$SLNX May 1st News
Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen
May 01, 2014
OTC Disclosure & News Service
Houston, TX -
Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen
May 1 2014
Houston ? Solanbridge Group Inc. (OTC: SLNX) is pleased to announce the appointment of Dr. Mark T. Cullen to the Scientific Advisory Board of SLNX. "We are proud to announce that Dr. Mark Cullen has agreed to join our Board to develop medical products that utilize cannabidiol (?CBD?), one of the many active ingredients derived from marijuana,? stated Charles R. Shirley, Chairman of the Board and Managing Director of Solanbridge. ?Dr. Cullen?s amazing career as a medical doctor, a chemist, a researcher, and as an entrepreneur makes him uniquely qualified to develop products for Solanbridge that break new ground in the development of uses for CBD beyond the currently known uses for the treatment of brain damage, severe social anxiety, cancer, psychological disorders,? Shirley continued. ?We realized that with Dr. Cullen?s physical presence in the Lake Tahoe area that this is a part of the medical marijuana business that we can take immediately to the market in Nevada and California without having an indeterminate wait for licenses or other regulatory issues,? Shirley added. Nevada and California have already approved medical marijuana for patients.
Dr. Cullen?s resume fits nicely with the development of medical marijuana products. He is a Yale University-trained doctor and medical director, who had academic appointments at Yale University and University of Florida. Dr. Cullen has done collaborative work with the World Health Organization (WHO), the Center for Disease Control (CDC) and the National Institute of Health (NIH). He has been published in numerous periodicals and has contributed to an educational movie series by National Geographic. He is an entrepreneur who has developed start-up companies and has also worked as the CEO of multiple companies both public and private. He is an inventor who has created ultrasound desulfurization and heavy oil upgrade technology. His work has taken him throughout the world including Saudi Arabia, UAI, India, and South America.
Solanbridge is also encouraged by the changing public opinion landscape in certain U.S. jurisdictions and the potential for legislative changes toward less regulation of medical marijuana and potentially recreational marijuana use in Nevada, Alaska, Oregon, and Rhode Island. Medical marijuana is legal in 20 states. There is a movement toward medical marijuana legalization in Florida and Maryland, two jurisdictions where Solanbridge has a physical presence.
The Company continues to pursue a commercial grower?s license in Province of Nova Scotia. Plans have been developed to hire a full-time staff member to administer the application process, acquire a building, equip the building with a state-of-the-art security system, and build out all aspects of a commercial medical marijuana grower?s production facility. The MOU signed by the Company on March 29, 2014 still plans to close on time.
About Solanbridge Group Inc.
Solanbridge Group Inc. is based in Spring, Texas and is a diversified holding company looking to expand into the medical marijuana industry by developing a commercial grower?s license in the Province of Nova Scotia, Canada. Solanbridge's subsidiary, David's Steak and Seafood, in Melbourne Beach, Florida, is a classic, upscale steak house, which presents polished dining in an atmosphere of timeless elegance, offering guests the finest cuts of choice USDA meats, fresh seafood and much more.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Contact:
For further information, please contact:
Charles R. Shirley
Solanbridge Group Inc
charles@solanbridgegroup.com
832.225.1372
Copyright © 2014 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
$SLNX May 1st News
Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen
May 01, 2014
OTC Disclosure & News Service
Houston, TX -
Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen
May 1 2014
Houston ? Solanbridge Group Inc. (OTC: SLNX) is pleased to announce the appointment of Dr. Mark T. Cullen to the Scientific Advisory Board of SLNX. "We are proud to announce that Dr. Mark Cullen has agreed to join our Board to develop medical products that utilize cannabidiol (?CBD?), one of the many active ingredients derived from marijuana,? stated Charles R. Shirley, Chairman of the Board and Managing Director of Solanbridge. ?Dr. Cullen?s amazing career as a medical doctor, a chemist, a researcher, and as an entrepreneur makes him uniquely qualified to develop products for Solanbridge that break new ground in the development of uses for CBD beyond the currently known uses for the treatment of brain damage, severe social anxiety, cancer, psychological disorders,? Shirley continued. ?We realized that with Dr. Cullen?s physical presence in the Lake Tahoe area that this is a part of the medical marijuana business that we can take immediately to the market in Nevada and California without having an indeterminate wait for licenses or other regulatory issues,? Shirley added. Nevada and California have already approved medical marijuana for patients.
Dr. Cullen?s resume fits nicely with the development of medical marijuana products. He is a Yale University-trained doctor and medical director, who had academic appointments at Yale University and University of Florida. Dr. Cullen has done collaborative work with the World Health Organization (WHO), the Center for Disease Control (CDC) and the National Institute of Health (NIH). He has been published in numerous periodicals and has contributed to an educational movie series by National Geographic. He is an entrepreneur who has developed start-up companies and has also worked as the CEO of multiple companies both public and private. He is an inventor who has created ultrasound desulfurization and heavy oil upgrade technology. His work has taken him throughout the world including Saudi Arabia, UAI, India, and South America.
Solanbridge is also encouraged by the changing public opinion landscape in certain U.S. jurisdictions and the potential for legislative changes toward less regulation of medical marijuana and potentially recreational marijuana use in Nevada, Alaska, Oregon, and Rhode Island. Medical marijuana is legal in 20 states. There is a movement toward medical marijuana legalization in Florida and Maryland, two jurisdictions where Solanbridge has a physical presence.
The Company continues to pursue a commercial grower?s license in Province of Nova Scotia. Plans have been developed to hire a full-time staff member to administer the application process, acquire a building, equip the building with a state-of-the-art security system, and build out all aspects of a commercial medical marijuana grower?s production facility. The MOU signed by the Company on March 29, 2014 still plans to close on time.
About Solanbridge Group Inc.
Solanbridge Group Inc. is based in Spring, Texas and is a diversified holding company looking to expand into the medical marijuana industry by developing a commercial grower?s license in the Province of Nova Scotia, Canada. Solanbridge's subsidiary, David's Steak and Seafood, in Melbourne Beach, Florida, is a classic, upscale steak house, which presents polished dining in an atmosphere of timeless elegance, offering guests the finest cuts of choice USDA meats, fresh seafood and much more.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Contact:
For further information, please contact:
Charles R. Shirley
Solanbridge Group Inc
charles@solanbridgegroup.com
832.225.1372
Copyright © 2014 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
$SLNX May 1st News
Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen
May 01, 2014
OTC Disclosure & News Service
Houston, TX -
Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen
May 1 2014
Houston ? Solanbridge Group Inc. (OTC: SLNX) is pleased to announce the appointment of Dr. Mark T. Cullen to the Scientific Advisory Board of SLNX. "We are proud to announce that Dr. Mark Cullen has agreed to join our Board to develop medical products that utilize cannabidiol (?CBD?), one of the many active ingredients derived from marijuana,? stated Charles R. Shirley, Chairman of the Board and Managing Director of Solanbridge. ?Dr. Cullen?s amazing career as a medical doctor, a chemist, a researcher, and as an entrepreneur makes him uniquely qualified to develop products for Solanbridge that break new ground in the development of uses for CBD beyond the currently known uses for the treatment of brain damage, severe social anxiety, cancer, psychological disorders,? Shirley continued. ?We realized that with Dr. Cullen?s physical presence in the Lake Tahoe area that this is a part of the medical marijuana business that we can take immediately to the market in Nevada and California without having an indeterminate wait for licenses or other regulatory issues,? Shirley added. Nevada and California have already approved medical marijuana for patients.
Dr. Cullen?s resume fits nicely with the development of medical marijuana products. He is a Yale University-trained doctor and medical director, who had academic appointments at Yale University and University of Florida. Dr. Cullen has done collaborative work with the World Health Organization (WHO), the Center for Disease Control (CDC) and the National Institute of Health (NIH). He has been published in numerous periodicals and has contributed to an educational movie series by National Geographic. He is an entrepreneur who has developed start-up companies and has also worked as the CEO of multiple companies both public and private. He is an inventor who has created ultrasound desulfurization and heavy oil upgrade technology. His work has taken him throughout the world including Saudi Arabia, UAI, India, and South America.
Solanbridge is also encouraged by the changing public opinion landscape in certain U.S. jurisdictions and the potential for legislative changes toward less regulation of medical marijuana and potentially recreational marijuana use in Nevada, Alaska, Oregon, and Rhode Island. Medical marijuana is legal in 20 states. There is a movement toward medical marijuana legalization in Florida and Maryland, two jurisdictions where Solanbridge has a physical presence.
The Company continues to pursue a commercial grower?s license in Province of Nova Scotia. Plans have been developed to hire a full-time staff member to administer the application process, acquire a building, equip the building with a state-of-the-art security system, and build out all aspects of a commercial medical marijuana grower?s production facility. The MOU signed by the Company on March 29, 2014 still plans to close on time.
About Solanbridge Group Inc.
Solanbridge Group Inc. is based in Spring, Texas and is a diversified holding company looking to expand into the medical marijuana industry by developing a commercial grower?s license in the Province of Nova Scotia, Canada. Solanbridge's subsidiary, David's Steak and Seafood, in Melbourne Beach, Florida, is a classic, upscale steak house, which presents polished dining in an atmosphere of timeless elegance, offering guests the finest cuts of choice USDA meats, fresh seafood and much more.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Contact:
For further information, please contact:
Charles R. Shirley
Solanbridge Group Inc
charles@solanbridgegroup.com
832.225.1372
Copyright © 2014 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Where?
$MCII New A/S is 100M! FLOAT: 65,375,375 O/S: 96,675,375 ~ 100M
Change of control as per last filing..
On February 7, 2014, the majority ownership changed hands. In an agreement between majority shareholders, Amie Hingston and Stan Snopek (“Sellers”), and Success Holding Group, through its proxy, Diane Dalmy (“Buyer), the majority ownership of shares (139,300,000 restricted common stock and 2 shares of preferred shares), along with various promissory notes to third party vendors, were purchased for $110,000 by Success Holding Group. Ms. Dalmy represented authorization to sign on behalf of the buyer. The remainder amount after the purchase of the various promissory notes was, in turn, used to eliminate all liabilities against the company for services legally rendered, properly and timely invoiced, and duly recorded.
NEWS COMING ANYDAY NOW! GROUND PLAY!
$MCII New A/S is 100M! FLOAT: 65,375,375 O/S: 96,675,375 ~ 100M
Change of control as per last filing..
On February 7, 2014, the majority ownership changed hands. In an agreement between majority shareholders, Amie Hingston and Stan Snopek (“Sellers”), and Success Holding Group, through its proxy, Diane Dalmy (“Buyer), the majority ownership of shares (139,300,000 restricted common stock and 2 shares of preferred shares), along with various promissory notes to third party vendors, were purchased for $110,000 by Success Holding Group. Ms. Dalmy represented authorization to sign on behalf of the buyer. The remainder amount after the purchase of the various promissory notes was, in turn, used to eliminate all liabilities against the company for services legally rendered, properly and timely invoiced, and duly recorded.
NEWS COMING ANYDAY NOW! GROUND PLAY!
$MCII New A/S is 100M! FLOAT: 65,375,375 O/S: 96,675,375 ~ 100M
Change of control as per last filing..
On February 7, 2014, the majority ownership changed hands. In an agreement between majority shareholders, Amie Hingston and Stan Snopek (“Sellers”), and Success Holding Group, through its proxy, Diane Dalmy (“Buyer), the majority ownership of shares (139,300,000 restricted common stock and 2 shares of preferred shares), along with various promissory notes to third party vendors, were purchased for $110,000 by Success Holding Group. Ms. Dalmy represented authorization to sign on behalf of the buyer. The remainder amount after the purchase of the various promissory notes was, in turn, used to eliminate all liabilities against the company for services legally rendered, properly and timely invoiced, and duly recorded.
NEWS COMING ANYDAY NOW! GROUND PLAY!
$MCII New A/S is 100M! FLOAT: 65,375,375 O/S: 96,675,375 ~ 100M
Change of control as per last filing..
On February 7, 2014, the majority ownership changed hands. In an agreement between majority shareholders, Amie Hingston and Stan Snopek (“Sellers”), and Success Holding Group, through its proxy, Diane Dalmy (“Buyer), the majority ownership of shares (139,300,000 restricted common stock and 2 shares of preferred shares), along with various promissory notes to third party vendors, were purchased for $110,000 by Success Holding Group. Ms. Dalmy represented authorization to sign on behalf of the buyer. The remainder amount after the purchase of the various promissory notes was, in turn, used to eliminate all liabilities against the company for services legally rendered, properly and timely invoiced, and duly recorded.
NEWS COMING ANYDAY NOW! GROUND PLAY!